AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest AMSBIO Content
Product News
GLP-1R Reporter Cell Line for Diabetes / Obesity Research
AMSBIO has launched a Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line.
Product News
Products for Sustainable Food Development
AMSBIO offers a range of kits, media and reagents enabling development of food in a way that is not wasteful of our natural resources and is not detrimental to the environment or consumer health.
Product News
GMP Compliant Materials and Support for ATMP Manufacturing
AMSBIO is dedicated to helping its customers seamlessly translate their cutting-edge research into production products for clinical therapy. A comprehensive new resource has been added to the website.
Product News
GMP Collagen Type I Additive for Reinforcing Bioprinted Constructs
Produced using dry-spun 50 µm Collagen Type I fibers, AMSBIO has introduced the innovative CollaFibR™ additive proven to increase the shape fidelity and biological relevance of bioprinted constructs in hydrogels and bioinks.
Product News
GMP Compliant Cell Culture Medium Streamlines API Manufacture
AMSBIO has launched an enhanced GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium.
Product News
Regulatory Compliant Tissue Microarrays
AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.
Product News
Products and Services for Diversifying Preclinical Models
AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.
Product News
Novel Reagents Advance Research Into Parkinsons Disease and Sleep Disorders
AMSBIO describe how life science research groups are using their BioPORTER®, Detachin™, and SoluLyse™ reagents to make groundbreaking advances in Parkinson’s research, hypersomnia studies and eco-friendly microbial ester production.
Product News
Expanded Solutions for Seamless Stem Cell Research
AMSBIO announces the launch of its Expanded Stem Cell Synergy Solutions.
Product News
Travel Grants for Cancer and Stem Cell Researchers
AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.
Advertisement
